HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steffen Berweck Selected Research

Sialorrhea

12/2023Letter to the Editor Regarding: "Botulinum Toxin A in the Management of Pediatric Sialorrhea: A Systematic Review" Ann Otol Rhinol Laryngol. 2023 Feb 18; doi: 10.1177/00034894221078365.
1/2023Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children-update and practice recommendations.
5/2022[Therapy of Sialorrhea with Botulinum Toxin - An Update].
5/2022[Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults].
5/2022[Correction: Treatment of Sialorrhea with Botulinum Neurotoxin Type A - Consensus Practice Recommendations for Children and Adults].
1/2022Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis.
10/2021A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients.
8/2021Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children: SIPEXI.
2/2012Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence.
1/2007Secondary non-response due to antibody formation in a child after three injections of botulinum toxin B into the salivary glands.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steffen Berweck Research Topics

Disease

16Cerebral Palsy (Spastic Diplegia)
01/2022 - 01/2004
10Sialorrhea
12/2023 - 01/2007
6Movement Disorders (Movement Disorder)
12/2014 - 03/2003
5Dystonia (Limb Dystonia)
08/2023 - 03/2010
4Traumatic Brain Injuries (Traumatic Brain Injury)
11/2023 - 08/2021
4Muscle Spasticity (Spastic)
02/2011 - 03/2003
3Brain Injuries (Brain Injury)
04/2024 - 07/2023
3Stroke (Strokes)
01/2018 - 01/2008
3Paresis (Hemiparesis)
12/2014 - 03/2004
3Body Weight (Weight, Body)
11/2010 - 08/2004
2Epilepsy (Aura)
04/2023 - 01/2021
2Seizures (Absence Seizure)
04/2023 - 01/2021
2Deglutition Disorders (Dysphagia)
05/2022 - 01/2022
2Nervous System Diseases (Neurological Disorders)
08/2021 - 02/2012
2Torticollis (Wryneck)
01/2021 - 01/2007
2Inborn Genetic Diseases (Disease, Hereditary)
01/2020 - 10/2013
2Learning Disabilities (Learning Disability)
10/2013 - 01/2007
2Muscular Atrophy (Muscle Atrophy)
05/2013 - 07/2009
1Microphthalmos
08/2023
1Brain Edema (Cerebral Edema)
04/2023
1Chronic Disease (Chronic Diseases)
01/2022
1Injection Site Reaction
01/2022
1Muscle Weakness
01/2022
1Parkinson Disease (Parkinson's Disease)
10/2021
1Intellectual Disability (Idiocy)
08/2021
1Dysarthria (Spastic Dysarthria)
01/2021
1Neurodevelopmental Disorders
11/2020
1Nicolaides Baraitser syndrome
01/2020
1Vomiting
12/2019
1Consciousness Disorders
12/2019
1Vascular Malformations
12/2019
1Headache (Headaches)
12/2019
1Neurofibromatosis 1 (Neurofibromatosis Type I)
10/2013
1Pruritus (Itching)
06/2011
1Hypertension (High Blood Pressure)
06/2011
1Weight Loss (Weight Reduction)
06/2011
1Nervous System Mercury Poisoning (Minamata Disease)
06/2011
1Erythema
06/2011
1Tachycardia (Tachyarrhythmias)
06/2011
1Atrophy
07/2009
1Spinal Cord Injuries (Spinal Cord Injury)
01/2008
1Cerebral Infarction
01/2008
1Microcephaly
01/2007

Drug/Important Bio-Agent (IBA)

11Botulinum Toxins (Botulinum Toxin)IBA
05/2022 - 03/2003
8Type A Botulinum Toxins (Botox)FDA Link
12/2023 - 04/2006
7incobotulinumtoxinAFDA Link
01/2023 - 07/2009
3beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
04/2024 - 07/2023
2Valproic Acid (Depakote)FDA LinkGeneric
04/2023 - 01/2020
2EnzymesIBA
11/2020 - 07/2009
2Indicators and Reagents (Reagents)IBA
01/2018 - 02/2011
1retinoic acid receptor betaIBA
08/2023
1Phe Transfer RNAIBA
04/2023
1NeurotoxinsIBA
01/2023
1Proteins (Proteins, Gene)FDA Link
01/2023
1Cholinergic Antagonists (Anticholinergics)IBA
05/2022
1tyramine-deoxysorbitolIBA
10/2021
1Synaptosomal-Associated Protein 25IBA
10/2021
1Lamotrigine (Lamictal)FDA LinkGeneric
01/2021
1Nitrazepam (Serenade)IBA
01/2021
1purineIBA
11/2020
1BaclofenFDA LinkGeneric
10/2014
1Neurofibromin 1 (Neurofibromin)IBA
10/2013
1Lovastatin (Mevacor)FDA LinkGeneric
10/2013
1AntibodiesIBA
02/2012
1MercuryIBA
06/2011
1batrachotoxinin A 20-alpha-benzoateIBA
01/2007
1Neutralizing AntibodiesIBA
01/2007
1rimabotulinumtoxinBFDA Link
08/2004
1Acetylcholine (Acetylcholine Chloride)FDA Link
03/2004

Therapy/Procedure

12Therapeutics
01/2023 - 04/2006
3Injections
01/2023 - 07/2009
3Activities of Daily Living (ADL)
02/2019 - 12/2014
3Transcranial Magnetic Stimulation
10/2013 - 01/2008
2Deep Brain Stimulation
01/2021 - 03/2010
2Orthotic Devices (Orthosis)
11/2010 - 01/2008
1Craniotomy
04/2023
1Ketogenic Diet
01/2021
1Vagus Nerve Stimulation
01/2021
1Emergency Treatment
12/2019
1Chelation Therapy (Therapy, Chelation)
06/2011